The CDC said Friday that people who have Covid only need to stay at home until t...
In today's Pharmalittle roundup, we're reading about RSV vaccines' link to Guill...
Ironwood Pharmaceuticals’ short bowel syndrome drug performed well in a Phase 3 ...
Oncology startup FogPharma just closed a $145 million Series E round, the compan...
A befuddling rule change has led to serious disruptions in the world of communit...
Aletha Maybank, a member of the 2024 #STATUSList, is pushing to transform the cu...
In a searing letter, device lobby AdvaMed urged CMS to finalize a Medicare cover...
The UK MHRA has granted marketing authorisation for a new formulation of Amgen’s...
Simtra BioPharma has announced plans invest $250m for an expansion of its steril...
In addition to r/r multiple myeloma, the biotech is evaluating the drug as a tre...
Panama’s government expects to be a pioneer in the area through the centralisati...
During 2023, funding decreased by 43.2% compared to 2022 and by 52.3% compared t...
The top 20 biopharmaceutical companies saw prominent shifts in market capitalisa...
US FDA placed a partial clinical hold on HIV programme and a full hold on Covid-...
BlossomHill has secured $100m in a Series B financing round to advance its progr...
